Results of neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fuluorouracil for advanced esophageal cancer.

被引：1
|
作者：
Emi, Manabu
Hamai, Yoichi
Ibuki, Yuta
Okada, Morihito
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Hiroshima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.171
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
171
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Updated results of a randomized phase II trial for neoadjuvant versus adjuvant docetaxel/cisplatin chemotherapy in patients with locally advanced gastric cancer.
    Kim, Young Woo
    Ryu, Keun Won
    Choi, Il Ju
    Kook, Myeong-Cherl
    Park, Young Iee
    Kim, Hark K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [42] Comparing docetaxel plus cisplatin versus fluorouracil plus cisplatin in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy
    Xi, Mian
    Zhang, Peng
    Zhang, Li
    Yang, Ya-Di
    Liu, Shi-Liang
    Li, Yong
    Fu, Jian-Hua
    Liu, Meng-Zhong
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (08) : 683 - 689
  • [43] A pilot study of modified neoadjuvant docetaxel/cisplatin/5-FU (TPF) to concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC): Preliminary results
    Isla, D.
    Martinez-Trufero, J.
    Morales, S.
    Yubero, A.
    Lambea, J.
    Alvarez, I.
    Polo, E.
    Segui, M. A.
    Pujol, E.
    Pastor, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer
    Nomura, Hisanaga
    Hatogai, Ken
    Maki, Yosuke
    Mochizuki, Nobuo
    Tanaka, Masaki
    Saito, Shinichiro
    Daiko, Hiroyuki
    Kojima, Takashi
    Kawasaki, Toshikatsu
    SUPPORTIVE CARE IN CANCER, 2020, 28 (04) : 1849 - 1854
  • [45] Risk factors for febrile neutropenia in neoadjuvant docetaxel, cisplatin, and 5-fluorouracil chemotherapy for esophageal cancer
    Hisanaga Nomura
    Ken Hatogai
    Yosuke Maki
    Nobuo Mochizuki
    Masaki Tanaka
    Shinichiro Saito
    Hiroyuki Daiko
    Takashi Kojima
    Toshikatsu Kawasaki
    Supportive Care in Cancer, 2020, 28 : 1849 - 1854
  • [46] Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer
    Janinis, J
    Papadakou, M
    Panagos, G
    Panousaki, A
    Georgoulias, V
    Hatzidaki, D
    Lefantzis, D
    Dokianakis, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 227 - 231
  • [47] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Nishiwaki, Noriyuki
    Noma, Kazuhiro
    Kunitomo, Tomoyoshi
    Hashimoto, Masashi
    Maeda, Naoaki
    Tanabe, Shunsuke
    Sakurama, Kazufumi
    Shirakawa, Yasuhiro
    Fujiwara, Toshiyoshi
    ESOPHAGUS, 2022, 19 (04) : 626 - 638
  • [48] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Noriyuki Nishiwaki
    Kazuhiro Noma
    Tomoyoshi Kunitomo
    Masashi Hashimoto
    Naoaki Maeda
    Shunsuke Tanabe
    Kazufumi Sakurama
    Yasuhiro Shirakawa
    Toshiyoshi Fujiwara
    Esophagus, 2022, 19 : 626 - 638
  • [49] Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
    Maeda, Osamu
    Furune, Satoshi
    Kanda, Mitsuro
    Miyata, Kazushi
    Shimizu, Dai
    Sugita, Shizuki
    Nishida, Kazuki
    Ando, Masahiko
    Kodera, Yasuhiro
    Ando, Yuichi
    CANCER MEDICINE, 2024, 13 (02):
  • [50] Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer - Experience at a single institution
    Malaisrie, SC
    Untch, B
    Aranha, GV
    Mohideen, N
    Hantel, A
    Pickleman, J
    ARCHIVES OF SURGERY, 2004, 139 (05) : 532 - 538
12345